FOLH1 and prostate carcinoma: In this study, prostate-specific membrane antigen (PSMA) highly overexpressed in prostate cancer was actively targeted using PSMA peptide combined with AuNP for targeted delivery of silicon phthalocyanine (Pc4) PS.